US biotech major Amgen presented its fourth quarter and 2024 financial results late Tuesday, along with its guidance for 2025.

In Düsseldorf, Algiax Pharmaceuticals is working on a novel analgesic which could provide an effective alternative to opioids, according to new mid-stage data. The firm has just released Phase IIa ...